This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1py5

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1py5.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1py5.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1py5| PDB=1py5 | SCENE= }}
{{STRUCTURE_1py5| PDB=1py5 | SCENE= }}
-
'''Crystal Structure of TGF-beta receptor I kinase with inhibitor'''
+
===Crystal Structure of TGF-beta receptor I kinase with inhibitor===
-
==Overview==
+
<!--
-
We have expanded our previously reported series of pyrazole-based inhibitors of the TGF-beta type I receptor kinase domain (TbetaR-I) to now include new 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole analogues. Limited examination of the SAR of this new series in both enzyme and cell based in vitro assays has revealed selectivity differences with respect to p38 MAP kinase (p38 MAPK) depending on the nature of the 'warhead' group on the dihydropyrrolopyrazole ring. As with our original pyrazole series, phenyl substituents tended to show greater selectivity against p38 MAPK than those comprised of the quinoline-4-yl moiety. We have also achieved co-crystallization and X-ray analysis of compounds 3 and 15, two potent examples of this new series, with the TbetaR-I receptor kinase domain.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15177479}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15177479 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15177479}}
==Disease==
==Disease==
Line 31: Line 35:
[[Category: Receptor i]]
[[Category: Receptor i]]
[[Category: Tgf-beta]]
[[Category: Tgf-beta]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 05:38:12 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 12:13:08 2008''

Revision as of 09:13, 29 July 2008

Image:1py5.png

Template:STRUCTURE 1py5

Contents

Crystal Structure of TGF-beta receptor I kinase with inhibitor

Template:ABSTRACT PUBMED 15177479

Disease

Known disease associated with this structure: Loeys-Dietz syndrome, type 1A OMIM:[190181], Loeys-Dietz syndrome, type 2A OMIM:[190181]

About this Structure

1PY5 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain., Sawyer JS, Beight DW, Britt KS, Anderson BD, Campbell RM, Goodson T Jr, Herron DK, Li HY, McMillen WT, Mort N, Parsons S, Smith EC, Wagner JR, Yan L, Zhang F, Yingling JM, Bioorg Med Chem Lett. 2004 Jul 5;14(13):3581-4. PMID:15177479

Page seeded by OCA on Tue Jul 29 12:13:08 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1py5"
Personal tools